Table 1.
Characteristics of Included Trials
| Name | Timing | Pre‐op BB% (P‐C) | Mean age (years) (P‐C) | Male% (P‐C) | LVEF (P‐C) | AF definition | Exclusion criteria | Limitations |
|---|---|---|---|---|---|---|---|---|
| Imren et al. | PREOP | NA | 62.2–61.4 | 59–60 | 54–52 | 15 mins | CHF included | IOP Esmolol, OP CABG only |
| Lucio et al. | POSTOP | 65–63 | 59–62 | 72–74 | NA | Sustained symptom | EF<35% | Continuous ECG for only 3 days, BB WD |
| Wenke et al. | POSTOP | 61–56 | 63–64 | 79–75 | 63–62 | NK | EF<30% | BB WD, Continuous ECG for 2 days only |
| Paull et al. | POSTOP | NK | NK | NK | NK | 15 mins | EF<30% | No demographic information available |
| Yazicioglu et al. | PREOP | NA | 57–55 | 80–75 | 52–50 | NK | EF<30% | Small study group |
| Bert et al. | POSTOP | 76–72 | 63.6–63.8 | 76–83 | 49–49 | 5 mins | EF<20%, AVR included | BB WD |
| Connolly et al. | POSTOP | 82–79 | 63–62 | 78–80 | NK | 1 min | CHF, Valve surgery included | BB WD |
| Babin‐Ebell et al. | POSTOP | 61–65 | 61–64 | 76–83 | 67–62 | NK | EF<40% | BB WD, used SVT |
| Gun et al. | POSTOP | NK | NK | NK | NK | NK | NK | Only abstract is available |
| Ali et al. | POSTOP | 100–100 | 65–63 | 74–69 | 59–56 | NK | EF<35% | BB WD, Continuous ECG for 3 days only |
Abbreviations as in text. NS = nonspecific; NA = not applicable; NK = not known; min = minutes; IOP = intraoperative; OP = off‐pump; WD = withdrawal; P = prophylactic group, C = control group.